Skip to main content

Table 3 Expression levels in RCC of patients with/without development of metastatic disease

From: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

 

Metastatic disease

Relapse-free disease

p-value

 

n = 15

n = 23

 

miRNA-155

6.07*

15.58

0.095

 

1.80-21.03**

7.29-27.58

 

miRNA-141

0.072

0.102

0.682

 

0.033-0.671

0.046-0.181

 

miRNA-210

36.758

41.137

0.317

 

12.147-62.417

28.581-82.332

 

miRNA-200c

0.266

0.301

0.502

 

0.108-0.487

0.185-0.517

 

miRNA-106a

14.522

25.126

0.081

 

12.469-24.862

16.923-42.519

 

miRNA-106b

10.387

16.451

0.030

 

6.591-15.950

11.119-25.831

 

miRNA-200b

6.556

7.804

0.87

 

3.849-14.096

3.697-14.676

 

miRNA-182

0.302

0.081

0.194

 

0.051-0.728

0.036-0.321

 
  1. * Medians of expression level related to RNU6B with **25th and 75th percentiles.